ArticleHerz2019

In HFREF patients, sacubitril/valsartan, given at relatively low doses, does not lead to increased mortality or hospitalization : A retrospective cohort study.

R De Vecchis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.